Schrödinger-BMS collaboration centers on Bunsen for trillion-scale computational drug discovery

PartnershipPositive

AI Analysis

Summary

Schrödinger announced a strategic collaboration and software agreement with Bristol Myers Squibb centered on Bunsen, an agentic AI co-scientist platform designed for computational drug discovery at scale.

Importance:6/10

Sentiment:

0.60

collaborationAIcomputational chemistrydrug discoverysoftwarestrategic partnership

Related Companies

$BMY

Read the original article

Published by Drug Discovery & Development on August 17, 2026 8:49 PM

Read Original